Drug companies claim that statins have been proven to lower cholesterol and help prevent heart disease and strokes, leading many health experts to insist that they be artificially added to public water supplies, but dangerous side-effects buried by drug companies conducting statin trials have now come to light, in addition to the fact that “for three quarters of those taking them, they offer little or no value.”
A new study published in the Cochrane Library, which reviews drug trials, examined data from 14 drugs trials involving 34,000 patients and found evidence of “short-term memory loss, depression and mood swings,” that had been deliberately underplayed by the drug companies funding the research.